Valuation: Gedeon Richter

Market Cap 2,134B 6.78B 5.89B 5.47B 5.04B 9.5B 647B 9.67B 64.71B 25.34B 321B 25.45B 24.89B 1,081B P/E 2026 *
8.17x
P/E 2027 * 7.5x
Enterprise Value 1,819B 5.78B 5.02B 4.66B 4.3B 8.1B 552B 8.24B 55.17B 21.6B 274B 21.7B 21.22B 921B EV / Sales 2026 *
1.91x
EV / Sales 2027 * 1.67x
Free-Float
72.87%
Yield 2026 *
5.3%
Yield 2027 * 5.68%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 2017-10-31
Director of Finance/CFO - 2025-04-30
Chief Operating Officer - 2018-12-31
Director TitleAgeSince
Chairman 78 2016-12-31
Chairman 90 2024-02-29
Director/Board Member 65 2012-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 6.7B
+0.56%+2.99%+16.99%+75.76% 49.85B
-1.74%+3.05%+56.51%+109.86% 36.89B
-0.54%+3.63%-6.84%+24.50% 12.43B
-0.68%-0.99%+12.09%+74.10% 11.69B
+2.86%+0.96%+31.25%+132.30% 9.04B
-1.36%+2.18%+48.00%-5.72% 7.15B
-3.16%-0.44%+1.50%+174.22% 6.66B
+0.21%-3.66%-34.95%-1.46% 5.45B
+1.17%-0.65%+21.72%+112.68% 4.43B
Average +2.18%+2.15%+16.25%+77.36% 15.95B
Weighted average by Cap. +0.76%+2.83%+24.58%+82.23%

Financials

2026 *2027 *
Net sales 952B 3.02B 2.63B 2.44B 2.25B 4.23B 289B 4.31B 28.86B 11.3B 143B 11.35B 11.1B 482B 1,024B 3.25B 2.82B 2.62B 2.42B 4.55B 310B 4.64B 31.04B 12.15B 154B 12.21B 11.94B 518B
Net income 259B 824M 716M 665M 613M 1.15B 78.67B 1.18B 7.87B 3.08B 39.07B 3.09B 3.03B 131B 286B 909M 789M 733M 676M 1.27B 86.75B 1.3B 8.68B 3.4B 43.09B 3.41B 3.34B 145B
Net Debt -315B -999M -868M -806M -743M -1.4B -95.37B -1.43B -9.54B -3.74B -47.37B -3.75B -3.67B -159B -421B -1.34B -1.16B -1.08B -995M -1.88B -128B -1.91B -12.78B -5B -63.45B -5.03B -4.92B -213B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
11,700.00HUF
Average target price
12,931.29HUF
Spread / Average Target
+10.52%

Quarterly revenue - Rate of surprise